Clinical Trial Update: Selenium and Arsenic Pharmacodynamics [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/Phase 2 clinical trial from the University of Saskatchewan studying the pharmacodynamics of selenium and arsenic in chronic arsenic poisonin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arsenic Poisoning

Drugs mentioned

• Arsenic (Arsenic)
• Selenium (selenium)

Snippet

Sponsor: University of Saskatchewan | Conditions: Arsenic Poisoning Chronic | Phase 1, Phase 2 | Status: COMPLETED